Presented March News Today

One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive behavioral program to improve mood and pain symptoms.

A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.

Antibody-drug conjugates are a promising new option for gynecologic cancers, but they have a variety of ocular or vision-related adverse events that need to be appropriately monitored and managed.

There has been little improvement in addressing the shortage of pediatric rheumatologists over the past two decades, boding poorly for future patient care.

Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.

Response rates were superior to those seen with other single agents in patients with platinum-resistant disease and tumors positive for folate receptor alpha.

Two new studies show that adding immunotherapy with pembrolizumab or dostarlimab to chemotherapy significantly boosts progression-free survival in patients with advanced endometrial cancer.

Jacqueline Goldfingers new one-man play explores how virtual reality is used to treat post traumatic stress disorder among military veterans.

Some patients with side-effect concerns aiming to lessen their statin burden may prefer the treat-to-target approach, if they respond well to lesser-intensity statins, say researchers.

The device, a wrist-worn sensor that uses infrared light to detect the presence and concentration of cardiac troponin-I in the blood through the skin, predicted levels with 90% accuracy within 5 minutes.